Complete Decongestive Therapy Versus Compression Bandaging in Advanced Secondary Lymphedema

Edema Due to Obstruction of Lymph Vessels or Excision of Lymph Nodes Clinical Trial

Official title:

Complete Decongestive Therapy Versus Compression Bandaging in Advanced Secondary Lymphedema

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04749342
• Other study ID #: P.T.REC/012/002271
• Status: Completed
• Phase: N/A
• Start date: March 1, 2019
• Est. completion date: May 1, 2021

Study information

• Verified date: July 2021
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to:

Find out the efficacy of using complete decongestive physiotherapy on limb volume in advanced secondary upper and lower extremity lymphedema patients.

Find out the efficacy of compression bandaging on limb volume in advanced lymphedema patients.

This study was conducted to compare between the efficacy of complete decongestive therapy (CDT) and compression bandaging in advanced secondary lower extremity lymphedema.

Description:

The study was conducted at the department of plastic surgery, Kasr Al-Ainy hospital. Sixty patients of both genders aged from 40 to 55 years old were participated in this study, and they were randomly assigned to two study groups.

Group I: Thirty patients received CDT (60 min of manual lymph drainage MLD, compression bandaging, exercises, and skin care).

Group II: Thirty patients received compression bandaging alone. The same bandaging scheme used for both groups. The therapy included 12 interventions performed 5 days a week, during the first two weeks in addition to another successive two sessions at the third week, i.e., for a total of twelve sessions.

Evaluation of limb volume using water volumetry and 4-cm truncated cone circumferential measurements were done before treatment application, after 6 sessions (post 1) and after 12 sessions (post 2).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: May 1, 2021
• Est. primary completion date: March 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 55 Years

Eligibility

Inclusion Criteria:

Patients with lower limb lymphedema (stage II and III) secondary lymphedema aged from 40 to 55 years old, with BMI less than 35 and duration of illness ranged from 3-9 years were included in the study

Exclusion Criteria:

the patients were excluded if they have acute erysipelas, acute thrombophlebitis phlebothrombosis and decompensated heart failure.

Related Conditions & MeSH terms

• Edema Due to Obstruction of Lymph Vessels or Excision of Lymph Nodes
• Lymphedema

Intervention

Other:
• Physiotherapy Treatment
Physical Therapy sessions for treatment of advanced Lymphedema Cases

Locations

Country	Name	City	State
Egypt	cairo University	Cairo	Dokky, Giza

Sponsors (1)

Lead Sponsor	Collaborator
Ahmed Mohamed Abdelrauf

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Limb Volume	girth Limb Measurement	1 Month